Has Illumina Lost Its Shine?
Cathie Wood lost her conviction and dumped the stock. Can Illumina get back on track?
Illumina(ILMN)
Nasdaq Global Select
ILMN
$456.16
$0.81
0.2%
Price as of June 18, 2021, 4:00 p.m. ET
View Interactive ILMN Charts
The company develops, manufactures, and markets next-generation life-science tools and integrated systems to analyze genetic variations and biological functions.
Interactive Chart
News & Analysis: Illumina
The Fool has written over 500 articles on Illumina.
Will Illumina Be a Trillion-Dollar Stock by 2035?
It'll cover a lot of ground in the next 14 years.
Is Illumina Sandbagging With Its Full-Year Guidance?
It just might be.
2 of the Best Healthcare Stocks You'll Find Today
The advice of Warren Buffett's biggest influencers supports these solid picks.
How Illumina's Q1 Results Delighted Investors
Nearly everything went right for the genomic sequencing pioneer.
Illumina Inc (ILMN) Q1 2021 Earnings Call Transcript
ILMN earnings call for the period ending March 31, 2021.
3 Biden Healthcare Stocks to Watch
The administration's focus on the Affordable Care Act, access to healthcare, and research may accelerate growth for these three stocks.
Is Illumina Still a Buy Without the GRAIL Acquisition?
Sometimes the most carefully laid plans hit unforeseen snags.
The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance
The gene sequencing giant has a couple of key challenges going forward.
This Unstoppable Stock Doesn't Pay a Dividend Yet, but It Could
This giant of the genomic revolution ticks nearly all the boxes dividend investors should look for.
